FDA Investigator Carolyn A Renshaw

Carolyn A Renshaw has conducted inspections on 5 sites in 2 countries as of 15 Oct 2007. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
5
Last Inspection Date:
15 Oct 2007
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Austria
FDA Investigators that have inspected at least one site in common with Carolyn A Renshaw:
Amir Alavi, Anastasia G Lolas, Andrew W Harmon, Angel K Sandhu, Anh M Lac, Anita Narula, PhD, Ann Marie Montemurro, Arie C Menachem, Ashar P Parikh, Bo Chi, PhD, Bonita S Chester, Brandy D Brown, Burnell M Henry, Candace Y Gomez Broughton, Carl Lee, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Christian D Lynch (CDL), Concepcion Cruz, Jr, Cynthia Jim, CSO, David G Eng, Dennis Cantellops Paite, Diane L Raccasi, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Eileen A Liu, Eliezar Ramos, Emmanuel Adu Gyamfi, PhD, Esra Toussaint, Gene D Arcy, Hai Lient Phung, Henry K Lau, Holly Brevig, Hung H Do, MS, Jacqueline Mdiaz Albertini, James E Keller, PhD, James R Evans, Janet L Bowen, Jeffrey M Watson, Jolanna A Norton, Jonathan G Matrisciano, Jose Acruz Gonzalez, Joseph Kutze, PhD, Joslyn K Brunelle, PhD, Kara D Dobbin, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kevin A Gonzalez, Kevin P Foley, Kouros Kangarli, Kula N Jha, Lance Mde Souza, MBA, Latorie S Jones, Laura Fontan, MS, Laurie Graham, LCDR Debra Emerson, Leslie D Wagner, Linan Ha, PhD, Linda Thai, Lindsey R Lyman, LT Daveta L Bailey, Lucila B Nwatu, Maria Cecilia Tami, PhD, Maria Joselopez Barragan, PhD, Mariza M Jafary, Marla A Cassidy, Marshalette O Edwards, Martha T Olone, Mary E Farbman, PhD, Michael Schmitt, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Milos Dokmanovic, PhD, Mra Mcculloughj, Natalia Pripuzova, PhD, Nicholas L Hunt, Omotunde O Osunsanmi, Pankaj H Amin, Patricia F Hughes, PhD, Paula A Trost, Penny H Mccarver, Peter E Baker, Prabhu P Raju, Prajakta A Varadkar, Qing Joanna Zhou, PhD, Ram Sihag, PhD, Raquel Gonzalez Rivera, Raymond T Oji, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Roger F Zabinski, Rose Ashley, Ruth Moore, PhD, Sang Bong Lee, Santos E Camara, Scott N Lim, Sean R Marcsisin, Sharon K Thoma, PharmD, Sherri J Jackson, Sidney B Priesmeyer, Stephanie A Slater, MS, Steven Fong, MS, PhD, Susan M Jackson, Thomas J Arista, Thomas R Withers, Thuy T Nguyen, LCDR, Uduak M Inokon, Uttaniti Limchumroon (Tom), Viviana Matta, Wayne E Seifert, William V Millar, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD

Carolyn A Renshaw's Documents

Publish Date Document Type Title
February, 2000 FDA 483 Genentech, Inc. - Form 483, 2000-02-14
February, 2000 EIR Genentech, Inc. - EIR, 2000-02-14
February, 2005 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2005-02-25
June, 2006 FDA 483 Indivior Manufacturing LLC - Form 483, 2006-06-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more